ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,291Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1171

$685K Total Retail Price of All Prescriptions

Rank: 106 out of 1171

763 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 763 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 763 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 12,123 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 637 589 1 1
AMLODIPINE BESYLATE 532 502 2 2
LISINOPRIL 493 465 3 3
HYDROCHLOROTHIAZIDE 435 425 4 9
METFORMIN HCL 411 370 5 7
OMEPRAZOLE 385 344 6 5
PRAVASTATIN SODIUM 266 226 7 13
GLIPIZIDE ER 266 253 7 86
TRAMADOL HCL 256 226 9 18
ATORVASTATIN CALCIUM 249 239 10 10
FUROSEMIDE 246 218 11 6
ATENOLOL 198 183 12 15
LOSARTAN POTASSIUM 196 177 13 14
CITALOPRAM HBR 185 174 14 22
PREDNISONE 184 169 15 39
LEVOTHYROXINE SODIUM 175 153 16 4
METOPROLOL SUCCINATE 165 157 17 17
GABAPENTIN 155 132 18 16
CRESTOR 154 123 19 27
ZOLPIDEM TARTRATE 146 140 20 21
DONEPEZIL HCL 140 140 21 24
METOPROLOL TARTRATE 138 132 22 11
POTASSIUM CHLORIDE 136 115 23 19
TRIAMTERENE-HCTZ 134 134 24 58
GLIPIZIDE XL 129 124 25 124
LOVASTATIN 124 124 26 36
ALLOPURINOL 118 118 27 31
TAMSULOSIN HCL 115 114 28 28
NEXIUM 113 109 29 25
SERTRALINE HCL 112 104 30 23
TRAZODONE HCL 112 99 30 37
INDAPAMIDE 111 103 32 199
DIOVAN 111 111 32 32
TERAZOSIN HCL 109 100 34 143
GLIMEPIRIDE 96 72 35 34
GLYBURIDE 89 89 R 36 97
HYDROCODONE-ACETAMINOPHEN 88 58 S3 37 8
QUINAPRIL HCL 87 84 38 156
CARVEDILOL 86 86 39 20
SPIRIVA 86 74 39 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 79 41 26
PROAIR HFA 85 71 41 49
BUMETANIDE 83 74 43 93
IPRATROPIUM BROMIDE 77 76 44 172
AMLODIPINE BESYLATE-BENAZEPRIL 75 73 45 70
BENAZEPRIL HCL 73 73 46 83
RANITIDINE HCL 69 62 47 38
DIOVAN HCT 68 49 48 65
FENOFIBRATE 67 60 49 81
WARFARIN SODIUM 65 62 50 12
VERAPAMIL ER 64 64 51 91
ALENDRONATE SODIUM 64 64 51 33
NAMENDA 64 64 51 42
INSULIN SYRINGE 64 50 51 71
LOSARTAN-HYDROCHLOROTHIAZIDE 63 56 55 40
ADVAIR DISKUS 61 61 56 51
KLOR-CON 10 61 50 56 126
CYMBALTA 60 53 58 64
SYNTHROID 60 48 58 48
MELOXICAM 58 56 60 56
PAROXETINE HCL 58 58 60 62
ENALAPRIL MALEATE 58 45 60 73
AMOXICILLIN 57 51 63 111
CEPHALEXIN 53 42 64 104
FINASTERIDE 52 48 65 88
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 52 65 109
DILTIAZEM 24HR ER 51 51 67 112
GLIPIZIDE 51 51 67 47
MECLIZINE HCL 51 50 67 115
AGGRENOX 50 41 70 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.